These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 31637597)

  • 1. Guest Editorial: Perspectives on HIV and other age-related neurological diseases.
    Langford TD; Gordon J
    J Neurovirol; 2019 Oct; 25(5):619-621. PubMed ID: 31637597
    [No Abstract]   [Full Text] [Related]  

  • 2. Aging, comorbidities, and the importance of finding biomarkers for HIV-associated neurocognitive disorders.
    Rosenthal J; Tyor W
    J Neurovirol; 2019 Oct; 25(5):673-685. PubMed ID: 30868422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychiatric morbidity in HIV patients.
    Khouzam HR; Donnelly NJ; Ibrahim NF
    Can J Psychiatry; 1998 Feb; 43(1):51-6. PubMed ID: 9494747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-infection and comorbidities: a complex mix.
    Petoumenos K; Law M
    Lancet HIV; 2015 Jul; 2(7):e265-6. PubMed ID: 26423249
    [No Abstract]   [Full Text] [Related]  

  • 5. High prevalence of neurocognitive disorders observed among adult people living with HIV/AIDS in Southern Ethiopia: A cross-sectional study.
    Debalkie Animut M; Sorrie MB; Birhanu YW; Teshale MY
    PLoS One; 2019; 14(3):e0204636. PubMed ID: 30883557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ageing and inflammation in patients with HIV infection.
    Nasi M; De Biasi S; Gibellini L; Bianchini E; Pecorini S; Bacca V; Guaraldi G; Mussini C; Pinti M; Cossarizza A
    Clin Exp Immunol; 2017 Jan; 187(1):44-52. PubMed ID: 27198731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological soft signs as a marker of cognitive impairment severity in people living with HIV.
    Toro P; Ceballos ME; Pesenti J; Inostroza M; Valenzuela D; Henríquez F; Forno G; Herold C; Schröder J; Calderón J
    Psychiatry Res; 2018 Aug; 266():138-142. PubMed ID: 29870954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular cognitive impairment and HIV-associated neurocognitive disorder: a new paradigm.
    Cysique LA; Brew BJ
    J Neurovirol; 2019 Oct; 25(5):710-721. PubMed ID: 30635846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remediating HIV-Associated Neurocognitive Disorders via Cognitive Training: A Perspective on Neurocognitive Aging.
    Vance DE; Cody SL; Moneyham L
    Interdiscip Top Gerontol Geriatr; 2017; 42():173-186. PubMed ID: 27875832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease.
    Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D
    J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor function declines over time in human immunodeficiency virus and is associated with cerebrovascular disease, while HIV-associated neurocognitive disorder remains stable.
    M Elicer I; Byrd D; Clark US; Morgello S; Robinson-Papp J
    J Neurovirol; 2018 Aug; 24(4):514-522. PubMed ID: 29696578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive Reserve Over the Lifespan: Neurocognitive Implications for Aging With HIV.
    Vance DE; Lee L; Muñoz-Moreno JA; Morrison S; Overton T; Willig A; Fazeli PL
    J Assoc Nurses AIDS Care; 2019; 30(5):e109-e121. PubMed ID: 30865059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbid depression and apathy in HIV-associated neurocognitive disorders in the era of chronic HIV infection.
    Cysique LA; Brew BJ
    Handb Clin Neurol; 2019; 165():71-82. PubMed ID: 31727231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-associated psychosis: a study of 20 cases. San Diego HIV Neurobehavioral Research Center Group.
    Sewell DD; Jeste DV; Atkinson JH; Heaton RK; Hesselink JR; Wiley C; Thal L; Chandler JL; Grant I
    Am J Psychiatry; 1994 Feb; 151(2):237-42. PubMed ID: 8296896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The current understanding of overlap between characteristics of HIV-associated neurocognitive disorders and Alzheimer's disease.
    Rubin LH; Sundermann EE; Moore DJ
    J Neurovirol; 2019 Oct; 25(5):661-672. PubMed ID: 30671777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The burden of HIV-associated neurocognitive impairment in Australia and its estimates for the future.
    Cysique LA; Bain MP; Brew BJ; Murray JM
    Sex Health; 2011 Dec; 8(4):541-50. PubMed ID: 22127041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and Risk Factors of HIV-Associated Neurocognitive Disorders in Rural Southwestern Uganda.
    Namagga JK; Rukundo GZ; Voss JG
    J Assoc Nurses AIDS Care; 2019; 30(5):531-538. PubMed ID: 31461736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of HIV dementia with HIV infection.
    Nath A; Schiess N; Venkatesan A; Rumbaugh J; Sacktor N; McArthur J
    Int Rev Psychiatry; 2008 Feb; 20(1):25-31. PubMed ID: 18240060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV-associated neurocognitive disorders: the relationship of HIV infection with physical and social comorbidities.
    Tedaldi EM; Minniti NL; Fischer T
    Biomed Res Int; 2015; 2015():641913. PubMed ID: 25815329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microvascular Function in Aging Among Women Living with HIV.
    Monsuez JJ; Belin C; Bouchaud O
    Curr HIV/AIDS Rep; 2016 Dec; 13(6):392-398. PubMed ID: 27709330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.